(Q38591851)

4 September 2017

title

The role for surgery in high-risk prostate cancer (English)

1 reference

4 September 2017

3

Morgan Rouprêt

1 reference

4 September 2017

2

Shahrokh F Shariat

1 reference

4 September 2017

Cécilia Lanchon

1

1 reference

4 September 2017

publication date

23 September 2015

1 reference

Wiener Medizinische Wochenschrift

4 September 2017

published in

1 reference

4 September 2017

volume

165

1 reference

4 September 2017

issue

19-20

1 reference

4 September 2017

page(s)

395-400

1 reference

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

CCAFU Recommendations 2013: Prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

NCCN clinical practice guidelines in oncology: prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Pathological findings and prostate-specific antigen outcomes after laparoscopic radical prostatectomy for high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Predicting 15-year prostate cancer specific mortality after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Operative details and oncological and functional outcome of robotic-assisted laparoscopic radical prostatectomy: 400 cases with a minimum of 12 months follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10354-015-0389-Y

Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy

21 January 2018

1 reference

12 December 2020

Long-term outcome following radical prostatectomy for Gleason 8-10 prostatic adenocarcinoma

1 reference

12 December 2020

Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients

1 reference

12 December 2020

Intermediate-Term Potency, Continence, and Survival Outcomes of Radical Prostatectomy for Clinically High-Risk or Locally Advanced Prostate Cancer

1 reference

12 December 2020

External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer

1 reference

12 December 2020

Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy

1 reference

12 December 2020

A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer

1 reference

12 December 2020

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

1 reference

12 December 2020

10.1007/S10354-015-0389-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

4 September 2017

1032651657

0 references

1 reference